マイクロバイオームシーケンスサービス市場：サービス（サンプル調製、シーケンス、ライブラリー調製）、タイプ（アンプリコンシーケンス、ホールゲノムシーケンス）、技術（合成によるシーケンス、ナノポアシークエンス）、エンドユーザー別 - 2028年までの世界予測

Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028

マイクロバイオームシーケンスサービス市場は、2023年の284百万米ドルから2028年には14.3%の年率で555百万米ドルに成長すると予測されます。治療薬開発におけるマイクロバイオームシーケンスの用途の拡大は、この... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年5月17日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	193	221	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

マイクロバイオームシーケンスサービス市場は、2023年の284百万米ドルから2028年には14.3%の年率で555百万米ドルに成長すると予測されます。治療薬開発におけるマイクロバイオームシーケンスの用途の拡大は、この市場で活動するプレーヤーにとって重要な機会となっています。マイクロバイオームシーケンスは、研究以外の用途も拡大しており、皮膚マイクロバイオームの研究や口腔マイクロバイオームシーケンスなど、治療薬開発に活用されることが増えています。これらのアプリケーションは、健康と病気におけるマイクロバイオータの役割の理解を進め、皮膚の健康と口腔の健康を改善するための標的介入の開発に情報を提供する可能性を秘めています。

"シーケンスおよびライブラリー調製分野が予測期間中に最も高い成長を目撃する"
サービスに基づいて、マイクロバイオームシーケンスサービス市場は、サンプル調製サービス、シーケンスおよびライブラリ調製サービス、データ解析サービスに区分されます。マイクロバイオームシーケンスおよびライブラリー調製では、16S rRNAシーケンス、ショットガンメタゲノミクス、qPCR検査、短鎖脂肪酸（SCFA）分析など、さまざまなアプローチが採用されています。16S rRNAシーケンスの需要が高いことが、このセグメントの成長を後押しすると予想されます。
"2022年の世界のマイクロバイオームシーケンスサービス市場では、合成によるシーケンス（SBS）セグメントが45％の最大シェアを占めています。"
技術に基づき、世界のマイクロバイオームシーケンスサービス市場は、SBS（sequencing by synthesis）、SBL（sequencing by ligation）、ナノポアシーケンス、その他の技術に分類されます。SBS技術は、4つの蛍光標識ヌクレオチドを使用して、フローセル表面上の数百万個のクラスターを並行して配列します。
「予測期間中、アジア太平洋地域が最も高いCAGRを記録すると推定される。
マイクロバイオームシーケンスサービス市場は、北米、欧州、アジア太平洋地域（APAC）、中南米、中東・アフリカ（MEA）に区分されます。アジア太平洋地域は、健康と病気におけるマイクロバイオームの重要性に対する認識の高まり、個別化医療に対する需要の高まり、シーケンス技術の進歩などにより、マイクロバイオームシーケンスサービスの市場が最も急速に成長すると予想されます。

供給側の一次インタビューの内訳、企業タイプ別、呼称別、地域別：
- 回答者別サプライサイド（70％）、デマンドサイド（30％）。
- 呼称別マネージャークラス（45％）、CXO・ディレクタークラス（35％）、エグゼクティブ（25％）。
- 地域別北米（20％）、欧州（10％）、アジア太平洋（55％）、中南米（10％）、中東アフリカ（5％）。

レポート掲載企業一覧
- チャールズリバーラボラトリーズ（米国）
- ユーロフィンズサイエンティフィック（フランス）
- BGI (中国)
- CosmosID（米国）
- マイクロバ（豪州）
- QIAGEN (ドイツ)
- マイクロバイオームインサイツ(カナダ)
- BaseClear(オランダ)
- CD Genomics（米国）
- Zymo Research（米国）
- オラシュアテクノロジーズ（米国）
- MR DNA（米国）
- エレミッド・ゲノミック・サービス（米国）
- クリニカル・マイクロバイオミクス A/S（デンマーク）
- ノボジーン社（中国(中国)
- EzBiome社（米国）
- ボスター・バイオロジカル・テクノロジー（米国）
- Zifo（インド）
- omics2view.consulting GbR (ドイツ)
- マクロジェン社（韓国）

調査対象
本レポートでは、マイクロバイオームシーケンスサービス市場をサービス、タイプ、技術、エンドユーザー、地域に基づいて調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、マイクロマーケットについて、その成長動向、展望、マイクロバイオームシーケンスサービス市場全体への貢献度に関して調査しています。本レポートでは、5つの主要地域に関して、市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは、以下のポイントに関する洞察を提供します：

- マイクロバイオームシーケンスサービス市場の成長に影響を与える主要な推進要因（メタゲノム解析の需要増加、ヒトマイクロバイオーム治療薬開発への注目の高まり、解析用高度インフラの高コスト）、阻害要因（熟練者の不足）、機会（治療薬開発におけるマイクロバイオームシーケンスの用途拡大）、課題（解析用サンプル調製/微生物の分離に関する問題）についての分析。
- サービスの開発/革新：新たに開始されたサービスに関する詳細な洞察と、マイクロバイオームシーケンスサービス市場の技術的評価。
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域にわたるマイクロバイオームシーケンスサービス市場を分析しています。
- 市場の多様化：新サービス、未開拓の地域、最近の開発、マイクロバイオームシーケンスサービス市場への投資に関する詳細な情報を提供します。
- 競合他社の評価：マイクロバイオームシーケンスサービス市場におけるCharles River Laboratories International, Inc.（米国）、Eurofins Scientific（フランス）、BGI（中国）などの主要企業の市場シェア、成長戦略、サービス提供について詳細に評価します。また、本レポートは、関係者がマイクロバイオームシーケンスサービス市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。

ページTOPに戻る

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 32
1.7.1 RECESSION IMPACT 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.2 PRIMARY DATA 36
FIGURE 2 MICROBIOME SEQUENCING SERVICES MARKET: BREAKDOWN OF PRIMARIES 36
2.2 MARKET ESTIMATION METHODOLOGY 37
FIGURE 3 MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 37
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 38
FIGURE 5 ILLUSTRATIVE EXAMPLE OF COMPANY REVENUE ANALYSIS, 2022 39
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 40
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 40
2.3 MARKET GROWTH RATE PROJECTIONS 41
FIGURE 7 MICROBIOME SEQUENCING SERVICES MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 41
FIGURE 8 MICROBIOME SEQUENCING SERVICES MARKET: GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 9 DATA TRIANGULATION METHODOLOGY 43
2.5 RESEARCH ASSUMPTIONS 44
2.6 RISK ANALYSIS 44
2.7 IMPACT OF RECESSION ON MICROBIOME SEQUENCING SERVICES MARKET 44
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 45
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 45
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 45
3 EXECUTIVE SUMMARY 46
FIGURE 10 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 11 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 12 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 47
FIGURE 13 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 48
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICROBIOME SEQUENCING SERVICES MARKET 49
4 PREMIUM INSIGHTS 50
4.1 MICROBIOME SEQUENCING SERVICES MARKET OVERVIEW 50
FIGURE 15 GROWING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET 50
4.2 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE AND COUNTRY (2023) 51
FIGURE 16 SEQUENCING AND LIBRARY PREPARATION SERVICES TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN MICROBIOME SEQUENCING SERVICES MARKET IN 2023 51
4.3 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 51
FIGURE 17 SHOTGUN SEQUENCING SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 18 MICROBIOME SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 4 MICROBIOME SEQUENCING SERVICES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 53
5.2.1.1 Increasing demand for metagenomic sequencing 53
5.2.1.2 Growing focus on human microbiome therapeutics development 54
FIGURE 19 ROLE OF MICROBIOME SEQUENCING IN THERAPEUTICS DEVELOPMENT 54
5.2.1.3 High cost of advanced infrastructure for sequencing 55
TABLE 5 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021) 55
5.2.2 RESTRAINTS 56
5.2.2.1 Dearth of skilled personnel 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Expanding applications of microbiome sequencing in therapeutics development 56
5.2.4 CHALLENGES 57
5.2.4.1 Issues related to sample preparation/isolation of microbes for sequencing 57
5.3 TECHNOLOGY ANALYSIS 57
5.4 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MICROBIOME SEQUENCING SERVICE PROVIDERS 59
5.5 VALUE CHAIN ANALYSIS 60
FIGURE 21 VALUE CHAIN ANALYSIS OF MICROBIOME SEQUENCING SERVICES MARKET 60
5.6 ECOSYSTEM MARKET MAP 61
FIGURE 22 ECOSYSTEM OF MICROBIOME SEQUENCING SERVICES MARKET 61
5.7 PORTER’S FIVE FORCES ANALYSIS 61
TABLE 6 MICROBIOME SEQUENCING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 61
5.7.1 THREAT OF NEW ENTRANTS 61
5.7.2 THREAT OF SUBSTITUTES 61
5.7.3 BARGAINING POWER OF SUPPLIERS 61
5.7.4 BARGAINING POWER OF BUYERS 62
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 62
5.8 REGULATORY ANALYSIS 62
5.8.1 NORTH AMERICA 62
5.8.1.1 US 62
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 63
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 63
5.8.1.2 Canada 63
5.8.2 EUROPE 64
5.8.3 ASIA PACIFIC 65
5.8.3.1 China 65
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 65
5.8.3.2 Japan 65
5.8.3.3 India 66
5.8.4 LATIN AMERICA 66
5.8.5 MIDDLE EAST 66
5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS: GENOMICS, MICROBIOME RESEARCH, AND METAGENOMICS 67
5.9 PRICING ANALYSIS 68
TABLE 11 AVERAGE SELLING PRICE, BY SERVICE AND TYPE 68
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS 69
5.10 KEY CONFERENCES AND EVENTS IN 2023–2024 70
TABLE 12 MICROBIOME SEQUENCING/METAGENOMIC SEQUENCING/NGS CONFERENCES, 2023–2024 70
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 72
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SEQUENCING SERVICES 72
FIGURE 24 CRITERIA FOR OUTSOURCING SEQUENCING SERVICES 72
6 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE 73
6.1 INTRODUCTION 74
TABLE 13 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 74
6.2 SAMPLE PREPARATION 74
6.2.1 NEED FOR SPECIFIC SAMPLE PREPARATION PROTOCOLS BASED ON SAMPLE TYPE TO DRIVE GROWTH 74
TABLE 14 MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 15 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 16 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 17 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 18 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 76
6.3 SEQUENCING AND LIBRARY PREPARATION 76
6.3.1 SEQUENCING AND LIBRARY PREPARATION SERVICES TO DOMINATE MARKET DURING FORECAST PERIOD 76
TABLE 19 MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 20 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 21 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 22 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 23 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.4 DATA ANALYSIS 78
6.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE GROWTH 78
TABLE 24 MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 25 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 26 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 28 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 80
7 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE 81
7.1 INTRODUCTION 82
TABLE 29 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
7.2 AMPLICON SEQUENCING 82
7.2.1 HIGH ACCURACY OF 16S AMPLICON SEQUENCING TO DRIVE ADOPTION 82
TABLE 30 AMPLICON SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 31 NORTH AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 32 EUROPE: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 33 ASIA PACIFIC: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 34 LATIN AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
7.3 WHOLE-GENOME SEQUENCING 84
7.3.1 ACCURATE REFERENCE GENOMES GENERATED FOR MICROBIAL IDENTIFICATION TO BOOST MARKET 84
TABLE 35 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 36 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 37 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 38 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 39 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.4 SHOTGUN SEQUENCING 86
7.4.1 ADVANCEMENTS IN DATA ANALYSIS SOLUTIONS TO SUPPORT ADOPTION 86
TABLE 40 SHOTGUN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 41 NORTH AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 42 EUROPE: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 43 ASIA PACIFIC: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 44 LATIN AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.5 OTHER TYPES 89
TABLE 45 OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 46 NORTH AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 47 EUROPE: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 48 ASIA PACIFIC: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 49 LATIN AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
8 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY 91
8.1 INTRODUCTION 92
TABLE 50 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 92
8.2 SEQUENCING BY SYNTHESIS (SBS) 92
8.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME 92
TABLE 51 MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 52 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 53 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 54 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 55 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 94
8.3 SEQUENCING BY LIGATION (SBL) 94
8.3.1 INCREASING DEMAND FOR SBL IN FOOD MICROBIOME RESEARCH TO BOOST GROWTH 94
TABLE 56 MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 57 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 58 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 59 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 60 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 96
8.4 NANOPORE SEQUENCING 96
8.4.1 ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES 96
TABLE 61 MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 62 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 63 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 64 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 65 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 98
8.5 OTHER TECHNOLOGIES 99
TABLE 66 MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 67 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 68 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 69 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 70 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
9 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER 101
9.1 INTRODUCTION 102
TABLE 71 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 102
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 102
9.2.1 ROBUST FUNDING FOR MICROBIOME-BASED THERAPEUTICS TO DRIVE MARKET 102
TABLE 72 MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 73 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 74 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 75 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 76 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
9.3 ACADEMIC AND RESEARCH INSTITUTES 105
9.3.1 EXPANDING APPLICATIONS OF MICROBIOME RESEARCH TO DRIVE GROWTH 105
TABLE 77 MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 78 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 79 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 80 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 81 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107
9.4 OTHER END USERS 107
TABLE 82 MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 83 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 84 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 85 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 86 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
10 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION 110
10.1 INTRODUCTION 111
FIGURE 25 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 111
TABLE 87 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 112
10.2 NORTH AMERICA 112
FIGURE 26 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT 113
TABLE 88 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 89 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 114
TABLE 90 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 91 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115
TABLE 92 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing awareness of microbiome research to drive growth 115
TABLE 93 US: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 116
TABLE 94 US: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 95 US: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 117
TABLE 96 US: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 117
10.2.2 CANADA 117
10.2.2.1 Increasing prevalence of chronic diseases to boost microbiome research 117
TABLE 97 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 118
TABLE 98 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 99 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 119
TABLE 100 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 119
10.2.3 NORTH AMERICA: IMPACT OF RECESSION 119
10.3 EUROPE 120
TABLE 101 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 102 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 121
TABLE 103 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 104 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 122
TABLE 105 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 122
10.3.1 GERMANY 122
10.3.1.1 Rapidly increasing government funding to support growth 122
TABLE 106 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 123
TABLE 107 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 108 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
TABLE 109 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.3.2 UK 124
10.3.2.1 Significant government investments in genomics research to propel growth 124
TABLE 110 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 125
TABLE 111 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 112 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 113 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10.3.3 FRANCE 126
10.3.3.1 Growing number of microbiome sequencing startups to propel growth 126
TABLE 114 HUMAN MICROBIOME STARTUPS IN FRANCE 127
TABLE 115 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 127
TABLE 116 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 117 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 118 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.3.4 ITALY 129
10.3.4.1 Increasing use of microbiome services in clinical research to drive growth 129
TABLE 119 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 129
TABLE 120 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 121 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 130
TABLE 122 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 130
10.3.5 SPAIN 131
10.3.5.1 Increasing prevalence of chronic diseases to drive market 131
TABLE 123 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 131
TABLE 124 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 125 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 132
TABLE 126 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.3.6 REST OF EUROPE 132
TABLE 127 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 133
TABLE 128 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 129 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 130 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.3.7 EUROPE: IMPACT OF RECESSION 134
10.4 ASIA PACIFIC 135
FIGURE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT 136
TABLE 131 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 132 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 137
TABLE 133 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 134 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
TABLE 135 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 138

10.4.1 CHINA 138
10.4.1.1 Increasing investments in R&D to drive growth 138
TABLE 136 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 139
TABLE 137 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 138 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 139 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 140
10.4.2 JAPAN 140
10.4.2.1 Significant growth in geriatric population to present opportunities for market growth 140
TABLE 140 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 141
TABLE 141 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 142 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 142
TABLE 143 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.4.3 INDIA 142
10.4.3.1 Increasing prevalence of chronic diseases to support growth 142
TABLE 144 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 143
TABLE 145 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 146 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 144
TABLE 147 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.4.4 REST OF ASIA PACIFIC 144
TABLE 148 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 145
TABLE 149 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 150 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 151 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.4.5 ASIA PACIFIC: IMPACT OF RECESSION 146
10.5 LATIN AMERICA 146
TABLE 152 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 153 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 147
TABLE 154 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 155 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 156 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.5.1 BRAZIL 149
10.5.1.1 Growing adoption of next-generation sequencing technologies to propel growth 149
TABLE 157 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 149
TABLE 158 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 159 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 150
TABLE 160 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 150
10.5.2 REST OF LATIN AMERICA 150
TABLE 161 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 151
TABLE 162 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 163 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 151
TABLE 164 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 152
10.5.3 LATIN AMERICA: IMPACT OF RECESSION 152
10.6 MIDDLE EAST & AFRICA 153
TABLE 165 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 153
TABLE 166 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 167 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 168 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 154
10.6.1 MIDDLE EAST & AFRICA: IMPACT OF RECESSION 154
11 COMPETITIVE LANDSCAPE 155
11.1 OVERVIEW 155
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 156
FIGURE 28 STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2023 156
11.3 MARKET SHARE ANALYSIS 157
FIGURE 29 MICROBIOME SEQUENCING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 157
TABLE 169 MICROBIOME SEQUENCING SERVICES MARKET: DEGREE OF COMPETITION 157
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 158
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2022 158
11.5 COMPANY EVALUATION QUADRANT 159
11.5.1 STARS 159
11.5.2 EMERGING LEADERS 159
11.5.3 PERVASIVE PLAYERS 159
11.5.4 PARTICIPANTS 159
FIGURE 31 MICROBIOME SEQUENCING SERVICES MARKET: COMPANY EVALUATION QUADRANT, 2022 160
11.6 COMPETITIVE SCENARIO 161
TABLE 170 SERVICE LAUNCHES 161
TABLE 171 DEALS 161
12 COMPANY PROFILES 163
12.1 KEY PLAYERS 163
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 CHARLES RIVER LABORATORIES 163
TABLE 172 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 163
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 164
12.1.2 EUROFINS SCIENTIFIC 166
TABLE 173 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 166
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) 166
12.1.3 BGI GROUP 168
TABLE 174 BGI GROUP: BUSINESS OVERVIEW 168
12.1.4 COSMOSID 169
TABLE 175 COSMOSID: BUSINESS OVERVIEW 169
12.1.5 MICROBA 171
TABLE 176 MICROBA: BUSINESS OVERVIEW 171
12.1.6 QIAGEN N.V. 173
TABLE 177 QIAGEN N.V.: BUSINESS OVERVIEW 173
FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 174
12.1.7 MICROBIOME INSIGHTS 176
TABLE 178 MICROBIOME INSIGHTS: BUSINESS OVERVIEW 176
12.1.8 BASECLEAR 178
TABLE 179 BASECLEAR: BUSINESS OVERVIEW 178
12.1.9 CD GENOMICS 179
TABLE 180 CD GENOMICS: COMPANY OVERVIEW 179
12.1.10 ZYMO RESEARCH CORPORATION 181
TABLE 181 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW 181
12.1.11 ORASURE TECHNOLOGIES 183
TABLE 182 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW 183
FIGURE 35 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2022) 184
12.1.12 MR DNA 186
TABLE 183 MR DNA: BUSINESS OVERVIEW 186
12.1.13 EREMID GENOMIC SERVICES 187
TABLE 184 EREMID GENOMIC SERVICES: BUSINESS OVERVIEW 187
12.1.14 CLINICAL-MICROBIOMICS A/S 188
TABLE 185 CLINICAL-MICROBIOMICS A/S: BUSINESS OVERVIEW 188
12.1.15 NOVOGENE CO., LTD. 190
TABLE 186 NOVOGENE CO., LTD.: BUSINESS OVERVIEW 190
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 191
12.2.1 EZBIOME 191
12.2.2 BOSTER BIOLOGICAL TECHNOLOGY 191
12.2.3 ZIFO 192
12.2.4 OMICS2VIEW.CONSULTING GBR 192
12.2.5 MACROGEN, INC. 193
13 APPENDIX 194
13.1 DISCUSSION GUIDE 194
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 197
13.3 CUSTOMIZATION OPTIONS 199
13.4 RELATED REPORTS 199
13.5 AUTHOR DETAILS 200

ページTOPに戻る

Table of Contents

Summary

The microbiome sequencing services market is projected to grow from USD 284 million in 2023 to USD 555 million by 2028 at a CAGR of 14.3%. Expanding applications of microbiome sequencing in therapeutics development serves as a key opportunity for the players operating in this market. Microbiome sequencing is expanding its applications beyond research and is increasingly being utilized in therapeutics development, including the study of the skin microbiome and oral microbiome sequencing. These applications have the potential to advance the understanding of the role of microbiota in health and disease and inform the development of targeted interventions for improving skin health and oral health.

“Sequencing and library preparation segment to witness the highest growth during the forecast period.”
Based on service, the microbiome sequencing services market is segmented into sample preparation services, sequencing and library preparation services, and data analysis services. Different approaches are employed in microbiome sequencing and library preparation, including 16S rRNA sequencing, shotgun metagenomics, qPCR testing, and short-chain fatty acids (SCFA) analysis. High demand for 16S rRNA sequencing is expected to boost the growth of this segment.
“The sequencing by synthesis (SBS) segment accounted for the largest share of 45% of the global microbiome sequencing services market in 2022.”
Based on technology, the global microbiome sequencing services market is segmented into sequencing by synthesis (SBS), sequencing by ligation (SBL), nanopore sequencing, and other technologies. The SBS technology uses four fluorescently labeled nucleotides to sequence millions of clusters on the flow cell surface in parallel .The SBS technology has a wide customer base owing to its well-established precision in sequencing as well as its broad application base.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
The microbiome sequencing services market is segmented into North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). The Asia Pacific region is expected to be the fastest-growing market for microbiome sequencing services due to the increasing awareness of the importance of the microbiome in health and disease, rising demand for personalized medicine, and advancements in sequencing technologies.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Respondent: Supply Side (70%) , Demand side (30%)
• By Designation: Manager-level (45%), CXO and Director-level (35%), and Executives (25%)
• By Region: North America (20%), Europe (10%), AsiaPacific (55%), Latin America(10% ) and Middle EastAfrica(5%)

List of Companies Profiled in the Report
• Charles River Laboratories (US)
• Eurofins Scientific (France)
• BGI (China)
• CosmosID (US)
• Microba (Australia)
• QIAGEN (Germany)
• Microbiome Insights (Canada)
• BaseClear (Netherlands)
• CD Genomics (US)
• Zymo Research (US)
• OraSure Technologies (US)
• MR DNA (US)
• Eremid Genomic Services (US)
• Clinical-Microbiomics A/S (Denmark)
• Novogene Co., Ltd. (China)
• EzBiome (US)
• Boster Biological Technology (US)
• Zifo (India)
• omics2view.consulting GbR (Germany)
• Macrogen, Inc. (South Korea)

Research Coverage
This report studies the microbiome sequencing services market based on service, type, technology, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total microbiome sequencing services market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Analysis of key drivers (Increasing demand for metagenomic sequencing, growing focus on human microbiome therapeutics development, and high cost of advanced infrastructure for sequencing), restraints (dearth of skilled personnel), opportunities (Expanding applications of microbiome sequencing in therapeutics development), and challenges (Issues related to sample preparation/isolation of microbes for sequencing) influencing the growth of microbiome sequencing services market.
• Service Development/Innovation: Detailed insights on newly launched services, and technological assessment of the microbiome sequencing services market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the microbiome sequencing services market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the microbiome sequencing services market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Charles River Laboratories International, Inc. (US), Eurofins Scientific (France), BGI (China) among others in the microbiome sequencing services market. The report also helps stakeholders understand the pulse of microbiome sequencing services market and provides them information on key market drivers, restraints, challenges, and opportunities.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（sample）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオ薬物）の最新刊レポート

MarketsandMarkets社のBiotechnology分野での最新刊レポート

本レポートと同じKEY WORD（sample）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?